• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.高调控性有利于 SLC18A2 的基因选择,SLC18A2 是一种囊泡单胺转运体,对生命至关重要。
FASEB J. 2010 Jul;24(7):2191-200. doi: 10.1096/fj.09-140368. Epub 2010 Feb 24.
2
SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism.SLC18A2启动子单倍型与一种新型酒精中毒保护因子的鉴定。
Hum Mol Genet. 2005 May 15;14(10):1393-404. doi: 10.1093/hmg/ddi148. Epub 2005 Apr 13.
3
Gain-of-function haplotypes in the vesicular monoamine transporter promoter are protective for Parkinson disease in women.囊泡单胺转运体启动子中的功能获得性单倍型对女性帕金森病具有保护作用。
Hum Mol Genet. 2006 Jan 15;15(2):299-305. doi: 10.1093/hmg/ddi445. Epub 2005 Dec 8.
4
Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.溶质载体家族18成员2(SLC18A2)3'-非翻译区的基因变异与多囊卵巢综合征患者的血清促卵泡生成素浓度相关,并在体外调节基因表达。
Hum Reprod. 2016 Sep;31(9):2150-7. doi: 10.1093/humrep/dew162. Epub 2016 Jun 28.
5
hVMAT2: A Target of Individualized Medication for Parkinson's Disease.人囊泡单胺转运体2:帕金森病个体化药物治疗的一个靶点
Neurotherapeutics. 2016 Jul;13(3):623-34. doi: 10.1007/s13311-016-0435-5.
6
Genetic association analysis of 300 genes identifies a risk haplotype in SLC18A2 for post-traumatic stress disorder in two independent samples.对300个基因进行的遗传关联分析在两个独立样本中确定了溶质载体家族18成员2(SLC18A2)中与创伤后应激障碍相关的一个风险单倍型。
Neuropsychopharmacology. 2014 Jul;39(8):1872-9. doi: 10.1038/npp.2014.34. Epub 2014 Feb 14.
7
Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol and nicotine dependence.突触小泡胺转运体基因(SLC18A2)中的DNA多态性与酒精和尼古丁依赖的关联。
Neuropsychopharmacology. 2005 Dec;30(12):2263-8. doi: 10.1038/sj.npp.1300809.
8
Variation in the genes encoding vesicular monoamine transporter 2 and beta-1 adrenergic receptor and antidepressant treatment outcome.囊泡单胺转运体2和β-1肾上腺素能受体编码基因的变异与抗抑郁治疗结果
Psychiatr Genet. 2008 Oct;18(5):248-51. doi: 10.1097/YPG.0b013e3283052ff7.
9
Association study of the vesicular monoamine transporter gene SLC18A2 with tardive dyskinesia.SLC18A2 基因与迟发性运动障碍的关联研究。
J Psychiatr Res. 2013 Nov;47(11):1760-5. doi: 10.1016/j.jpsychires.2013.07.025. Epub 2013 Sep 6.
10
Genetic and epigenetic SLC18A2 silencing in prostate cancer is an independent adverse predictor of biochemical recurrence after radical prostatectomy.前列腺癌中SLC18A2基因和表观遗传沉默是根治性前列腺切除术后生化复发的独立不良预测因素。
Clin Cancer Res. 2009 Feb 15;15(4):1400-10. doi: 10.1158/1078-0432.CCR-08-2268.

引用本文的文献

1
Epistatic evidence for gender-dependant slow neurotransmission signalling in substance use disorders: PPP1R12B versus PPP1R1B.物质使用障碍中性别依赖的慢神经递质信号传递的上位证据:PPP1R12B 与 PPP1R1B。
EBioMedicine. 2020 Nov;61:103066. doi: 10.1016/j.ebiom.2020.103066. Epub 2020 Oct 21.
2
hVMAT2: A Target of Individualized Medication for Parkinson's Disease.人囊泡单胺转运体2:帕金森病个体化药物治疗的一个靶点
Neurotherapeutics. 2016 Jul;13(3):623-34. doi: 10.1007/s13311-016-0435-5.
3
Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury.囊泡单胺转运体的基因变异:与重度创伤性脑损伤后认知结果的初步关联
J Head Trauma Rehabil. 2017 Mar/Apr;32(2):E24-E34. doi: 10.1097/HTR.0000000000000224.
4
Genome-wide differential expression of synaptic long noncoding RNAs in autism spectrum disorder.自闭症谱系障碍中突触长链非编码RNA的全基因组差异表达
Transl Psychiatry. 2015 Oct 20;5(10):e660. doi: 10.1038/tp.2015.144.
5
Computational dissection of human episodic memory reveals mental process-specific genetic profiles.人类情景记忆的计算剖析揭示了特定心理过程的基因图谱。
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):E4939-48. doi: 10.1073/pnas.1500860112. Epub 2015 Aug 10.
6
Human dopamine transporter gene: differential regulation of 18-kb haplotypes.人类多巴胺转运体基因:18kb 单倍型的差异调控。
Pharmacogenomics. 2013 Sep;14(12):1481-94. doi: 10.2217/pgs.13.141.
7
Vesicular integrity in Parkinson's disease.帕金森病中的囊泡完整性。
Curr Neurol Neurosci Rep. 2013 Jul;13(7):362. doi: 10.1007/s11910-013-0362-3.
8
Edaravone prevents neurotoxicity of mutant L166P DJ-1 in Parkinson's disease.依达拉奉可预防帕金森病中突变 L166P DJ-1 的神经毒性。
J Mol Neurosci. 2013 Oct;51(2):539-49. doi: 10.1007/s12031-013-0022-8. Epub 2013 May 10.
9
Identification of an intronic cis-acting element in the human dopamine transporter gene.鉴定人多巴胺转运体基因内含子顺式作用元件。
Mol Biol Rep. 2012 May;39(5):5393-9. doi: 10.1007/s11033-011-1339-4. Epub 2011 Dec 13.
10
Edaravone guards dopamine neurons in a rotenone model for Parkinson's disease.依达拉奉可保护鱼藤酮诱导的帕金森病模型中的多巴胺神经元。
PLoS One. 2011;6(6):e20677. doi: 10.1371/journal.pone.0020677. Epub 2011 Jun 3.

本文引用的文献

1
The mammalian molecular clockwork controls rhythmic expression of its own input pathway components.哺乳动物的分子生物钟控制其自身输入通路组件的节律性表达。
J Neurosci. 2009 May 13;29(19):6114-23. doi: 10.1523/JNEUROSCI.0275-09.2009.
2
Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons.胞质多巴胺、钙和α-突触核蛋白之间的相互作用导致黑质神经元选择性死亡。
Neuron. 2009 Apr 30;62(2):218-29. doi: 10.1016/j.neuron.2009.01.033.
3
MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20.微小RNA-320通过靶向热休克蛋白20参与心肌缺血/再灌注损伤的调控。
Circulation. 2009 May 5;119(17):2357-2366. doi: 10.1161/CIRCULATIONAHA.108.814145. Epub 2009 Apr 20.
4
The proapoptotic dp5 gene is a direct target of the MLK-JNK-c-Jun pathway in sympathetic neurons.促凋亡基因dp5是交感神经元中MLK-JNK-c-Jun信号通路的直接靶点。
Nucleic Acids Res. 2009 May;37(9):3044-60. doi: 10.1093/nar/gkp175. Epub 2009 Mar 20.
5
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.与多发性硬化症相关的MHC II类等位基因HLA - DRB1*1501的表达受维生素D调控。
PLoS Genet. 2009 Feb;5(2):e1000369. doi: 10.1371/journal.pgen.1000369. Epub 2009 Feb 6.
6
Systems-level analysis of cell-specific AQP2 gene expression in renal collecting duct.肾集合管中细胞特异性水通道蛋白2(AQP2)基因表达的系统水平分析
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2441-6. doi: 10.1073/pnas.0813002106. Epub 2009 Feb 3.
7
Helioxanthin inhibits interleukin-1 beta-induced MIP-1 beta production by reduction of c-jun expression and binding of the c-jun/CREB1 complex to the AP-1/CRE site of the MIP-1 beta promoter in Huh7 cells.氦黄质通过降低c-jun表达以及c-jun/CREB1复合物与Huh7细胞中MIP-1β启动子的AP-1/CRE位点的结合,抑制白细胞介素-1β诱导的MIP-1β产生。
Biochem Pharmacol. 2008 Oct 30;76(9):1121-33. doi: 10.1016/j.bcp.2008.08.023. Epub 2008 Aug 27.
8
PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity.垂体腺苷酸环化酶激活肽38(PACAP38)可增加囊泡单胺转运体2(VMAT2)的表达并减轻甲基苯丙胺毒性。
Neuropeptides. 2008 Aug;42(4):423-34. doi: 10.1016/j.npep.2008.04.003. Epub 2008 Jun 3.
9
Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression.与海洛因滥用相关的阿片类神经肽基因型:多巴胺基调促成中脑边缘前脑啡肽表达的逆转。
Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):786-91. doi: 10.1073/pnas.0710902105. Epub 2008 Jan 9.
10
A network of dopaminergic gene variations implicated as risk factors for schizophrenia.一个被认为是精神分裂症风险因素的多巴胺能基因变异网络。
Hum Mol Genet. 2008 Mar 1;17(5):747-58. doi: 10.1093/hmg/ddm347. Epub 2007 Nov 27.

高调控性有利于 SLC18A2 的基因选择,SLC18A2 是一种囊泡单胺转运体,对生命至关重要。

High regulatability favors genetic selection in SLC18A2, a vesicular monoamine transporter essential for life.

机构信息

Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

FASEB J. 2010 Jul;24(7):2191-200. doi: 10.1096/fj.09-140368. Epub 2010 Feb 24.

DOI:10.1096/fj.09-140368
PMID:20181938
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2887259/
Abstract

SLC18A2 encodes the vesicular monoamine transporter 2 protein that regulates neurotransmission and reduces cytosolic toxicity of monoamines. Deletion of this gene causes lethality in mice, and DNA sequence variation in this gene is associated with alcoholism and Parkinson's disease, among other disorders. The Caucasian SLC18A2 promoter has at least 20 haplotypes (A-T), with A representing two-thirds of 1460 chromosomes. It is not known why A is selected in the human lineage. To understand the selection, here we took a functional approach by investigating the regulations of 4 representative haplotypes (A, C, G, and T) by 17 agents. We show that 76.5% of the agents were able to regulate A but only 11.8-23.5% of them regulated the 3 other infrequent ones, observing a positive correlation between haplotype frequency and regulatability. Pathway and molecular analyses revealed five signaling hubs that regulate the four haplotypes differentially, probably through targeting the polymorphic core promoter region. These findings suggest that greater diversity of transcriptional regulations is the driving force for the haplotype selection in SLC18A2.

摘要

SLC18A2 编码囊泡单胺转运体 2 蛋白,该蛋白调节神经递质传递并降低单胺的细胞溶质毒性。该基因的缺失会导致小鼠死亡,并且该基因的 DNA 序列变异与酒精中毒和帕金森病等疾病有关。白种人 SLC18A2 启动子至少有 20 种单倍型(A-T),其中 A 代表 1460 条染色体中的三分之二。目前尚不清楚为什么在人类谱系中选择了 A。为了了解选择的原因,我们通过研究 17 种药物对 4 种代表性单倍型(A、C、G 和 T)的调控,采用了一种功能方法。我们表明,76.5%的药物能够调节 A,但只有 11.8-23.5%的药物能够调节另外三种罕见的单倍型,观察到单倍型频率与可调节性之间存在正相关。通路和分子分析揭示了五个信号枢纽,它们通过靶向多态性核心启动子区域,差异调节这四个单倍型。这些发现表明,转录调控的更大多样性是 SLC18A2 中单倍型选择的驱动力。